$CBRS

Vassallo Steven sold $10.9M of CBRS (indirect holdings)

Vassallo Steven sold 50,000 indirectly-held shares of Cerebras Systems Inc. (CBRS) at an average of $218.18 ($216.38–$219.97, $10.91M total) across 5 trades on 2026-08-14.

Original reporting
SEC EDGAR · Vassallo Steven
Published Aug 18, 2026, 10:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 11:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, execution dates, price range, and post-transaction holdings for a director, which can marginally affect sentiment but not fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone is unlikely to drive a sustained repricing.

03

What to watch

The filing notes indirect holdings and no 10b5-1 plan, but it does not disclose the reason for sale or whether other insiders are trading, limiting inference.

Relevance 7/10Novelty 3/10Timing: filed Aug. 18, covering sales executed Aug. 14

Background

The article is an SEC Form 4 insider transaction disclosure for Cerebras Systems Inc. (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras Systems director Vassallo Steven sold about $10.9M of CBRS shares via an open-market sale across five trades on Aug. 14.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and should fade unless followed by additional disclosures.

Evidence & confidence

Form 4 provides transaction details (size, dates, prices) but no new company-specific operating or guidance information. Absence of a 10b5-1 plan can raise scrutiny, yet insider sales are common and not automatically bearish.

Market effects

No clear sector read-through from a single director sale without accompanying company news.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or liquidity needs and may not reflect negative expectations, especially given the multi-trade execution window.

Key entities

  • Cerebras Systems Inc.

    CBRS, the company whose director sold shares as reported on Form 4.

  • Vassallo Steven

    Director who reported an open-market sale of CBRS shares totaling about $10.9M.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSHighAI 8/10

CBRS Stock Surges 68% On Nasdaq Debut: Cathie Wood's ARK Buys Shares While Trimming TSMC, AMD

Cerebras Systems (CBRS) shares surged 68% on their Nasdaq debut, closing at $311.07, with a market cap of $95B. ARK ETFs bought 105,616 shares, while trimming stakes in TSMC and AMD. The IPO raised $5.6B, with strong demand highlighting investor interest in AI hardware. CBRS reported $510M in 2023 sales, up from $290.3M in 2024, and partners with OpenAI, Meta, AWS, and IBM.

$CBRSMed

CBRS Stock Slides As Cerebras Ramps AI Capacity And Growth

Cerebras Systems Inc. (CBRS) stock rose 10.73% on September 4, 2026, driven by investor optimism around AI chip adoption. The company reported Q2 2026 revenue of $510M and a loss of $451M, with a high price-to-sales multiple of 117x. Morgan Stanley reiterated its overweight rating, citing strong AI demand and partnerships. CBRS faces execution risks due to high spending on AI capacity expansion.

$CBRSMed

Cerebras Systems Stock Slides As Wall Street Backs Aggressive AI Expansion

Cerebras Systems Inc. (CBRS) stock rose 10.91% on September 4, 2026, driven by bullish sentiment around its AI chip advancements. The company reported quarterly revenue of $180.1M and a net loss of $450.5M, with a price-to-sales ratio of 117.36. Morgan Stanley reiterated its overweight rating, citing surging AI inference demand and expected revenue growth. However, risks include execution challenges in data center expansion and profitability concerns.

$CBRSMed

Cerebras Stock Jumps 12% as Finland Capacity Tests a $51 Billion Valuation

Cerebras Systems (CBRS) shares rose 12% to $213.26, nearing a $51B valuation. The surge followed a Finland data-center contract announcement, with plans for 50MW, 80MW, and 165MW stages. The stock initially fell 6.3% on the news but recovered. Cerebras has $8.6B in cash and $25.4B in performance obligations, with a 2026 revenue forecast of $880M-$890M.

$CBRSHighAI 8/10

Why is Cerebras Systems stock surging today?

Cerebras Systems stock rose 6.4% to $202.61 after announcing a 165 MW AI data center in Finland, partnering with Compute Nordic Finland. The company reported Q2 2026 revenue of $209.9M, beating estimates, and raised full-year guidance to $880M-$890M. Analysts and ARK Invest have shown support.